3 Spinal Muscular Atrophy Clinical Trials in Kansas City, MO (2026)

Q: How do I join a clinical trial in Kansas City?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Kansas City research site will contact you.

Recruiting Spinal Muscular Atrophy Studies in Kansas City

NCT06345729Recruiting

A Study of MK-1084 Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

This is a study evaluating the efficacy and safety of MK-1084 with pembrolizumab as first-line treatment in participants with locally advanced or metastatic non-small cell lung cancer (NSCLC) with ide...

Kansas City, MO600 participantsMerck Sharp & Dohme LLC

View Study Details

NCT06343402Recruiting

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

A first in human study to evaluate the safety and preliminary antitumor activity of BBO-8520, a KRAS G12C (ON and OFF) inhibitor, as a single agent and in combination with pembrolizumab and BBO-10203 ...

Kansas City, MO350 participantsTheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)

View Study Details

NCT04992780Recruiting

Comparing Hypo-fractionated Intensity- Modulated Radiation Therapy to Standard- Fractionated IMRT Along With Chemotherapy and Immunotherapy for Non-Small Cell Lung Cancer

The hypothesis for this study is that hypofractionated IMRT to 62.5 Gy in 25 fractions (2.5 Gy/fraction) with concurrent carboplatin and paclitaxel, followed by maintenance durvalumab will improve loc...

Kansas City, MO50 participantsUniversity of Kansas Medical Center

View Study Details

About Spinal Muscular Atrophy Clinical Trials in Kansas City

Spinal muscular atrophy (SMA) is a genetic neuromuscular disorder that causes loss of motor neurons, leading to progressive muscle weakness and atrophy. It is the leading genetic cause of infant death. Revolutionary gene therapies and SMN-enhancing drugs have transformed treatment.

There are currently 3 spinal muscular atrophy clinical trials recruiting participants in Kansas City, MO. These studies are seeking a combined 1,000 participants. Research is being sponsored by Merck Sharp & Dohme LLC, TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics), University of Kansas Medical Center. Clinical trial participation is free and participants receive study-related medical care at no cost.

Spinal Muscular Atrophy Clinical Trials in Kansas City — FAQ

Are there spinal muscular atrophy clinical trials in Kansas City?

Yes, there are 3 spinal muscular atrophy clinical trials currently recruiting in Kansas City, MO. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Kansas City?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Kansas City research site will contact you about next steps.

Are clinical trials in Kansas City free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Kansas City studies also compensate for your time and travel.

What spinal muscular atrophy treatments are being tested?

The 3 active trials in Kansas City are testing new therapies including novel drugs, biologics, and treatment approaches for spinal muscular atrophy.

Data updated July 13, 2026 from ClinicalTrials.gov